(1,3-Dimethyl-1H-pyrazol-4-yl)-methanol, 95.0%, 10g

2,2,2-Trifluoroethanol, min. 99.8%, for synthesis, 250 ml, glass packaging

1-(3-phenylpropyl)-1,4-diazepane bis(4-methylbenzenesulfonate), 95.0%, 25g

Piperazine-1,4-dicarbaldehyde, 95.0%, 500g

4-(3-Bromopropyl)-1,2-dimethoxybenzene, 98%, 5g

4-Chloro-3-methylphenylboronic Acid (contains varying amounts of Anhydride)5g

3-phenylpyridin-2-ylamine, 95.0%, 5g

Methyl 2-amino-6-bromoisonicotinate, 98%, 250mg

2-Hydroxybenzyl Alcohol>98.0%(GC)250g

Ethyl 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate, 98%, 1g

1-(1-BENZYLHEXAHYDROPYRROLO[3,4-B]PYRROL-5(1H)-YL)-2,2,2-TRIFLUOROETHAN-1-ONE, 95.0%, 2g

tert-Butyl 2-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate, 95.0%, 5g

2-methyl-4-(4-methylpiperazin-1-yl)-6-(piperazin-1-yl)pyrimidine, 95.0%, 250mg